Title

Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure

UMMS Affiliation

Department of Pediatrics; Program in Molecular Medicine

Publication Date

2001-8

Document Type

Article

Subjects

Adult; Anti-HIV Agents; Female; HIV Infections; *HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious

Disciplines

Immunology and Infectious Disease | Pediatrics

Abstract

The safety, toxicity and pharmacokinetics of nevirapine were studied in HIV-infected pregnant women beginning chronic therapy late in the third trimester and in their infants. Initial dose pharmacokinetic profiles in the pregnant women were similar to those seen in nonpregnant adults. Serum nevirapine concentrations fell below the 100-ng/ml target concentration by Day 7 of life in four infants, suggesting that nevirapine elimination is accelerated in these infants compared with newborns whose mothers receive only a single intrapartum nevirapine dose.

Source

Pediatr Infect Dis J. 2001 Aug;20(8):803-5. Link to article on publisher's website

Journal/Book/Conference Title

The Pediatric infectious disease journal

Related Resources

Link to Article in PubMed

PubMed ID

11734746

Share

COinS